Crude analysis | Adjusted analysis | |||||
---|---|---|---|---|---|---|
Blood loss | (Geometric) mean + (G)SD^{§} or number (%) | Percentage increase (95% CI) | p value of univariate analysis | Percentage increase (95% CI) |
Index patient* Data expressed in ml (95% CI) | p value of multivariate analysis |
Patient characteristics | – | |||||
^{10}LOG uterine weight^{ɸ} | 153.6; 2.0 | 84.8 (74.5–95.4) | < .001 | |||
BMI (increase/1 kg/m^{2}) | 28.5 ± 6.2 | 2.4 (1.8–3.0) | < .001 | |||
Previous procedures | - | |||||
Yes (versus no) | 1213 (45.7) | 13.1 (4.3–22.6) | < .001 | |||
Stage of endometriosis | < .001 | < .001 | ||||
No endometriosis | 67.3; 3.4 | Reference | Reference | 65.7 (57.2–75.6) | ||
Stage I | 71.4; 3.2 | 4.9 (−16.1–31.2) | .68 | 7.6 (− 12.3–31.9) | 70.7 (55.7–89.7) | .48 |
Stage II | 79.0; 2.8 | 16.0 (− 7.3–44.9) | .20 | 18.8 (− 3.2–45.6) | 78.0 (61.4–99.2) | .10 |
Stage III | 70.0; 3.6 | 27.9 (1–62.1) | .04 | 34.0 (8.0–66.4) | 88.1 (68.7–113.0) | .01 |
Stage IV | 106.4; 2.9 | 98.8 (56.7–152.4) | < .001 | 114.3 (72.1–166.7) | 140.8 (109.4–180.9) | < .001 |
Operative time | Number (%) | Percentage increase (95% CI) | P-value of univariate analysis | Percentage increase (95% CI) |
Index patient* Data expressed in min (95% CI) | p value of multivariate analysis |
Patient characteristics | – | |||||
^{10}LOG uterine weight^{ɸ} | 20.0 (18.1–21.8) | < .001 | ||||
BMI (increase/1 kg/m^{2}) | 1.0 (0.8–1.2) | < .001 | ||||
Previous procedures | – | |||||
Yes (versus no) | 3.8 (1.5–6.1) | <.001 | ||||
Stage of endometriosis | < 0.001 | < .001 | ||||
No endometriosis | 90.6; 1.5 | Reference | Reference | 92.0 (87.4–96.9) | ||
Stage I | 88.1; 1.5 | − 4.4 (− 10.1–1.7) | .16 | − 3.3 (− 8.6–2.1) | 88.9 (82.7–95.7) | .23 |
Stage II | 81.9; 1.5 | 0.3 (− 5.7–6.7) | .93 | 1.2 (− 4.3–6.9) | 93.1 (86.5–100.3) | .68 |
Stage III | 95.1; 1.5 | 15.3 (8.0–23.1) | < .001 | 17.0 (10.3–24.0) | 107.7 (99.8–116.2) | < .001 |
Stage IV | 117.6; 1.6 | 47.6 (38.0–57.6) | < .001 | 51.0 (42.3–60.3) | 139.1 (128.8–150.1) | < .001 |
Complications | Number (%) | Odds ratio (95% CI) | p value of univariate analysis | Odds ratio (95% CI) | – | p value of multivariate analysis |
Patient characteristics | – | |||||
^{10}LOG uterine weight^{ɸ} | 0.69 (0.56–0.82) | < .001 | ||||
BMI (increase/1 kg/m^{2}) | 1.00 (0.98–1.03) | .935 | ||||
Previous procedures | – | |||||
Yes (versus no) | 1.17 (0.87–1.58) | .305 | ||||
Stage of endometriosis | .72 | .62 | ||||
No endometriosis | 153 (6.8) | Reference | Reference | |||
Stage I (versus no) | 5 (2.9) | 1.27 (0.55–2.95) | .57 | 1.27 (0.54–2.98) | .59 | |
Stage II | 7 (4.0) | 0.69 (0.33–1.43) | .32 | 0.67 (0.32–1.36) | .26 | |
Stage III | 4 (2.3) | 1.23 (0.48–3.10)0.76 | .67 | 1.16 (0.45–2.96) | .76 | |
Stage IV | 6 (3.4) | (0.34–1.65) | .48 | 0.67 (0.30–1.50) | .34 |